adar poonawalla
Jump to
59 Results Found
  • Serum Institute’s inability to meet global commitment will disrupt vaccine supply chains: Gavi Jun 10, 2021 04:22 PM IST

    Serum Institute’s inability to meet global commitment will disrupt vaccine supply chains: Gavi

    By the end of June, global vaccine alliance staring at a shortfall of 190 million doses.

  • Address security concerns raised by Adar Poonawalla, Bombay High Court tells Maharashtra government Jun 02, 2021 09:48 AM IST

    Address security concerns raised by Adar Poonawalla, Bombay High Court tells Maharashtra government

    The Bombay High Court said Maharashtra's top officials must personally speak to Serum Institute of India (SII) CEO Adar Poonawalla, who recently went to London, and assure him of his safety upon his return to India.

  • Magma Fincorp announces key management changes; Adar Poonawalla takes charge as chairman May 31, 2021 05:14 PM IST

    Magma Fincorp announces key management changes; Adar Poonawalla takes charge as chairman

    Deshwal is currently a business head at ICICI Bank, responsible for its fast-growing services sector, including new age businesses. He is also responsible for driving the liability strategy for the corporate ecosystem at the bank.

  • Serum Institute of India disassociates itself from its executive's remarks on COVID-19 vaccination drive May 23, 2021 03:41 PM IST

    Serum Institute of India disassociates itself from its executive's remarks on COVID-19 vaccination drive

    Amid an acute shortage of COVID-19 vaccines in the country, SII executive director Suresh Jadhav on Friday alleged that the government began inoculating people from multiple age groups without taking into account the available stock of vaccines and the WHO guidelines.

  • Serum Institute's Adar Poonawalla exits Panacea Biotec, sells entire stake for Rs 118 crore May 17, 2021 09:48 PM IST

    Serum Institute's Adar Poonawalla exits Panacea Biotec, sells entire stake for Rs 118 crore

    The shares were picked by Serum Institute of India (SII). As per BSE block deal data, Poonawalla sold 31,57,034 scrips he held in the firm at a price of Rs 373.85 per share, taking the total deal value to Rs 118.02 crore.

  • Serum Institute of India to invest 240 million pounds in UK: Boris Johnson's Office May 04, 2021 09:38 AM IST

    Serum Institute of India to invest 240 million pounds in UK: Boris Johnson's Office

    The announcement comes a couple of hours ahead of a virtual bilateral summit between Prime Minister Narendra Modi and his British counterpart Boris Johnson. SII is already running phase 1 trials of its new one dose nasal vaccine in the UK, which may be produced in the country once approved.

  • COVID-19 vaccine shortage in India will continue till July, says Serum Institute CEO Adar Poonawalla May 03, 2021 02:11 PM IST

    COVID-19 vaccine shortage in India will continue till July, says Serum Institute CEO Adar Poonawalla

    The Serum Institute has been maligned by politicians and critics over the vaccine shortages, Adar Poonawalla tells Financial Times. "I have been victimised very unfairly and wrongly."

  • COVID-19 Vaccine | Covishield production in full swing: Serum Institute of India CEO Adar Poonawalla May 02, 2021 08:32 AM IST

    COVID-19 Vaccine | Covishield production in full swing: Serum Institute of India CEO Adar Poonawalla

    Serum Institute of India CEO Adar Poonawalla also confirmed that he had “an excellent meeting” with all partners and stakeholders in the United Kingdom.

  • Threats from powerful, head will be chopped off if I comment on elections or Kumbh: SII CEO Adar Poonawalla May 01, 2021 07:32 PM IST

    Threats from powerful, head will be chopped off if I comment on elections or Kumbh: SII CEO Adar Poonawalla

    Serum Institute of India boss Adar Poonawalla in interview to London Times reveals why he is in the UK and talks about the pressure to deliver vaccines in India.

  • Home Ministry issues Y category security for Adar Poonawalla Apr 28, 2021 08:01 PM IST

    Home Ministry issues Y category security for Adar Poonawalla

    Poonawalla, 40, is one of the key players in the country's fight against the COVID-19 pandemic.

  • Covishield prices for states reduced to Rs 300 a dose, says Serum's Adar Poonawalla Apr 28, 2021 05:33 PM IST

    Covishield prices for states reduced to Rs 300 a dose, says Serum's Adar Poonawalla

    The vaccine manufactured by Serum Institute of India was earlier priced at Rs 400 per dose for the state governments.

  • Adar Poonawalla-backed Wellness Forever working on $160 million IPO: Report Apr 26, 2021 02:43 PM IST

    Adar Poonawalla-backed Wellness Forever working on $160 million IPO: Report

    In November 2020, Wellness Forever had raised Rs 130 crore from HNIs led by Adar Poonawalla.

  • BJP MLA slams Serum Institute of India over anti-COVID vaccine pricing, calls its CEO Adar Poonawalla 'dacoit' Apr 22, 2021 05:53 PM IST

    BJP MLA slams Serum Institute of India over anti-COVID vaccine pricing, calls its CEO Adar Poonawalla 'dacoit'

    Gorakhpur MLA Radha Mohan Das Agrawal made the remarks after SII on Wednesday announced a price of Rs 600 per dose for Covishield supplies to private hospitals and Rs 400 per dose to state governments.

  • Covishield vaccine's revised prices still only 50% of global rates, says SII CEO Adar Poonawalla Apr 21, 2021 05:36 PM IST

    Covishield vaccine's revised prices still only 50% of global rates, says SII CEO Adar Poonawalla

    SII will never take advantage of the pandemic, we are losing Rs 150 per dose now, says Poonawalla.

  • Adar Poonawalla thanks PM Narendra Modi, FM Sitharaman for 'decisive policy changes, swift financial aid' Apr 20, 2021 02:00 PM IST

    Adar Poonawalla thanks PM Narendra Modi, FM Sitharaman for 'decisive policy changes, swift financial aid'

    Adar Poonawalla's tweet came a day after the Centre approved an advance of around Rs 3,000 crore to the Serum Institute of India. Poonawalla had earlier said that the amount would be needed to ramp up production capacity.

  • EXCLUSIVE | Diverging views emerge within government on whether to provide financial help to vaccine makers Apr 16, 2021 04:17 PM IST

    EXCLUSIVE | Diverging views emerge within government on whether to provide financial help to vaccine makers

    The difference of opinion has especially widened on whether the dire situation at hand requires the government to provide direct funding to the largest vaccine maker in the world.

  • India could resume vaccine exports by June, says Adar Poonawalla Apr 07, 2021 08:24 AM IST

    India could resume vaccine exports by June, says Adar Poonawalla

    The company is a key supplier for the U.N.-backed COVAX program that aims to distribute vaccines equitably in the world. On March 25, COVAX announced a major setback in its vaccine rollout because a surge in infections in India caused the Serum Institute of India to cater to domestic demand, resulting in a delay in global shipments of up to 90 million doses.

  • COVID-19: Will prioritise India's vaccine needs for next few months, says SII CEO Adar Poonawalla Apr 06, 2021 06:36 PM IST

    COVID-19: Will prioritise India's vaccine needs for next few months, says SII CEO Adar Poonawalla

    Adar Poonawalla said that the Serum Institute of India has already delivered over 100 million doses to the government and is currently producing 65-70 million doses per month.

  • Covovax trials begin in India, hope to launch it by September 2021: Adar Poonawalla Mar 27, 2021 02:29 PM IST

    Covovax trials begin in India, hope to launch it by September 2021: Adar Poonawalla

    In August 2020, American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.

  • Serum Institute's Adar Poonawalla rents mansion in London's Mayfair for record $69,000 a week: Report Mar 25, 2021 10:30 AM IST

    Serum Institute's Adar Poonawalla rents mansion in London's Mayfair for record $69,000 a week: Report

    The CEO of Serum Institute of India has reportedly leased a 25,000 square feet property in London's Mayfair from Polish billionaire Dominika Kulczyk.

  • COVID-19 | Vaccine exports to UK to be temporarily halted, says Adar Poonawalla Mar 18, 2021 10:15 PM IST

    COVID-19 | Vaccine exports to UK to be temporarily halted, says Adar Poonawalla

    The second batch of five million doses that SII is due to export to the UK will only be delivered once it is green-lighted by the Indian government.

  • Adar Poonawalla says reaching WHO's 2021 goal of 2 billion doses will be challenging Mar 17, 2021 08:59 AM IST

    Adar Poonawalla says reaching WHO's 2021 goal of 2 billion doses will be challenging

    Countries are holding on to their supplies and restricting access to material required to manufacture more doses of vaccines against COVID-19, Poonawalla

  • Svasti Microfinance raises Rs 31 crore from Adar Poonawalla, others Mar 12, 2021 03:38 PM IST

    Svasti Microfinance raises Rs 31 crore from Adar Poonawalla, others

    In 2015, Svasti had raised funds from billionaire Adar Poonawalla, who subsequently invested in all follow-on rounds and now in the current round as well.

  • COVID-19 vaccine tracker| India may emerge as second largest vaccine maker after the US: Report Feb 15, 2021 06:44 PM IST

    COVID-19 vaccine tracker| India may emerge as second largest vaccine maker after the US: Report

    Prior to COVID-19 pandemic, India had been producing 60 percent of the world's vaccines for various diseases at an affordable rate.

  • 'Vaccines are forever', says Anand Mahindra tagging Adar Poonawalla in a parody vaccine advertisement Feb 12, 2021 04:19 PM IST

    'Vaccines are forever', says Anand Mahindra tagging Adar Poonawalla in a parody vaccine advertisement

    In this advertisement, a man is seen proposing to his girlfriend with a dose of the vaccine instead of a ring. "Inoculate yourself... with love," the ad suggests before concluding with a shot of the Pfizer vaccine which is "not available anywhere".

Sections